Exxonmobil Holdings Corporation (XOM) vs Chevron Corporation (CVX)
XOM's balance sheet and scale versus CVX's margins, yield and cheaper multiples in near-identical integrated oil
XOM and CVX are both US mega-cap integrated oil and gas companies with similar forward P/Es (13.33× for XOM, 13.07× for CVX) and similar reported growth, so Qanvo's growth category shows no clear leader (50 each). CVX leads Qanvo's valuation (80 vs 20), profitability and quality (83 vs 17), earnings momentum (67 vs 33) and technical momentum (80 vs 20) categories. XOM leads financial resilience (80 vs 20) and lower risk profile (75 vs 25), and has longer-run price returns of 160.0% over 5 years versus 87.3% for CVX. Analysts' estimates point to lower EPS next fiscal year for both (-9.52% XOM, -10.31% CVX), and both multiples sit above the sector median forward P/E of 11.23×. These are relative ranks within this pair, not absolute ratings.
Business overview
Both are US-listed, mega-cap integrated oil and gas companies in the Energy sector (industry: Oil & Gas Integrated), so their business models are broadly similar. Exxon Mobil has a market cap of $692.25B against $422.91B for Chevron, roughly 1.6 times larger. Exxon's profile describes three divisions (Upstream, Downstream and Chemical) plus petrochemicals and carbon capture and storage work. Chevron's profile describes Upstream and Downstream segments, including liquefied natural gas, pipelines and a gas-to-liquids plant. By fiscal 2025 revenue, Exxon reports $323.90B in total, split 57.51% non-US and 42.49% United States, with Energy Products at 75.47% of product revenue. Chevron reports $184.43B, with Downstream at 70.96% and Upstream at 28.98% of product revenue. Chevron's geographic breakdown in the facts is labelled by segment, so it is not a true regional split and cannot be compared with Exxon's. Exxon has 57,900 employees versus 43,039 at Chevron.
- Exxon's market cap of $692.25B is above Chevron's $422.91B.
- Exxon's fiscal 2025 revenue of $323.90B compares with $184.43B for Chevron.
- Exxon has a stated Chemical division, while Chevron's profile lists only Upstream and Downstream segments.
- Chevron's Downstream share of 70.96% of product revenue is a similar order to Exxon's Energy Products at 75.47%, though the segment definitions differ.
Valuation
Trailing P/E is 17.04× for Exxon and 15.68× for Chevron. Forward P/E, based on analyst estimates, is close: 13.33× versus 13.07×. Chevron is cheaper on EV/EBITDA (6.90× versus 8.67×) and price/sales is similar (1.87× for Chevron, 1.78× for Exxon, which is slightly lower). Chevron's free-cash-flow yield is 8.06% against 6.21% for Exxon. No PEG ratio is provided for either. Qanvo's valuation scorecard names Chevron the cheaper of the two (80 versus 20, relative ranks). Against each company's own 5-year trailing P/E history, Exxon's 17.04× sits above its median of 14.20× (range 6.92× to 26.21×), while Chevron's 15.68× is just below its median of 15.72× (range 8.13× to 61.22×). Versus Energy peers, both trade above the sector median trailing P/E of 12.99× and forward P/E of 11.23×; Exxon is at the 74th percentile on trailing P/E and Chevron at the 70th. Chevron's discount is not clearly explained by weaker fundamentals: it leads on margins and the quality scorecard. Exxon's premium may partly reflect its stronger balance sheet and lower risk scores.
- Chevron's trailing P/E of 15.68× is below Exxon's 17.04×, and its EV/EBITDA of 6.90× is below Exxon's 8.67×.
- Chevron's free-cash-flow yield of 8.06% is above Exxon's 6.21%.
- Exxon's trailing P/E is above its 5-year median of 14.20×, while Chevron's is in line with its median of 15.72×.
- Both forward P/Es (13.33× and 13.07×) are above the sector median of 11.23×.
Growth
Reported growth is similar in direction. Over the last year, revenue grew 19.48% at Exxon and 20.75% at Chevron; last-quarter year-over-year revenue growth was 32.61% versus 35.43%. EPS growth over the last year was 41.42% for Exxon and 92.26% for Chevron, and 111.36% versus 178.02% for the latest quarter. Over three years, revenue compounded at -6.69% for Exxon and -7.85% for Chevron, and EPS at -20.35% and -28.69%, reflecting the fall from the 2022 peak. Qanvo's growth scorecard shows no clear leader (50 each). The annual history shows the cycle: Exxon's diluted EPS went from 13.26 in 2022 to 6.7 in 2025, and Chevron's from 18.28 to 6.63. Quarterly EPS rebounded sharply in Q2 and Q3 of fiscal 2026 (Exxon 3.48 and 3.72; Chevron 6.11 and 5.06) after weak Q1 results of 1 and 1.11. Analyst estimates point to a reversal: next-fiscal-year EPS growth is -9.52% for Exxon and -10.31% for Chevron, with consensus EPS of 13.69 and 18.18 for the current year, falling to 12.39 and 16.31 the year after. These are opinions, not reported results.
- Chevron's last-year EPS growth of 92.26% is above Exxon's 41.42%, though both come off a weak base.
- Last-year revenue growth is close: 20.75% for Chevron versus 19.48% for Exxon.
- Three-year revenue compounding is negative for both, at -6.69% for Exxon and -7.85% for Chevron.
- Analysts' estimated next-year EPS growth is negative for both: -9.52% for Exxon and -10.31% for Chevron.
Profitability, cash flow & financial health
Chevron leads the Qanvo profitability and quality scorecard (83 versus 17 for Exxon Mobil, a relative rank within this pair). Its trailing margins are higher on every line: gross 34.73% versus 25.44%, operating 17.76% versus 12.43%, net 11.95% versus 10.46%, and free cash flow margin 15.09% versus 11.07%. Return on invested capital is also higher at Chevron (14.73% versus 13.24%), but return on equity is the reverse (Exxon Mobil 15.44% versus 14.04%), reflecting Exxon Mobil's larger equity base against its earnings. In dollars, Exxon Mobil produced more free cash flow ($42.96B versus $34.07B) on far larger revenue ($388.23B versus $225.78B). Both showed strong improvement: operating margin rose 1.44% at Exxon Mobil and 9.71% at Chevron over one year, and free cash flow growth was 80.71% versus 120.92%. Growth is turning into better economics at both, more so at Chevron. Exxon Mobil leads on resilience (80 versus 20). Net debt/EBITDA is 0.27× versus 0.32×, debt/equity 0.13× versus 0.17×, interest coverage 77.19× versus 29.45×. Chevron has the higher current ratio (1.34× versus 1.19×). Both balance sheets are conservative.
- Chevron's operating margin of 17.76% is above Exxon Mobil's 12.43%.
- Exxon Mobil's free cash flow is $42.96B versus Chevron's $34.07B, but Chevron's free cash flow margin is higher at 15.09% versus 11.07%.
- Exxon Mobil's interest coverage of 77.19× compares with Chevron's 29.45×.
- Return on equity favors Exxon Mobil (15.44% versus 14.04%), while return on invested capital favors Chevron (14.73% versus 13.24%).
Shareholder returns & capital allocation
Chevron offers the higher income: dividend yield 3.26% versus 2.49% for Exxon Mobil, with a quarterly payment of $1.78 versus $1.07. Chevron's payout ratio is also higher at 51.57% versus 42.75%, leaving Exxon Mobil somewhat more room relative to earnings. Both list 29 years of dividend growth in the data; over three years the dividend grew 6.39% at Chevron versus 4.06% at Exxon Mobil. Chevron's next ex-dividend date is Nov 18, 2026. Share count is the clearest difference. Exxon Mobil's shares changed by -4.41% over the past year, indicating net buybacks, while Chevron's rose 0.87%. Fiscal 2025 repurchases were $20.27B at Exxon Mobil versus $12.08B at Chevron, with dividends paid of $17.23B versus $12.75B. Chevron's fiscal 2025 buybacks and dividends combined ($24.83B) exceeded its free cash flow of $16.59B, while Exxon Mobil's combined outlays ($37.50B) exceeded its $23.61B. Trailing free cash flow yield is higher at Chevron (8.06% versus 6.21%).
- Chevron's dividend yield of 3.26% is above Exxon Mobil's 2.49%.
- Exxon Mobil's payout ratio of 42.75% is below Chevron's 51.57%.
- Exxon Mobil's share count fell 4.41% over one year while Chevron's rose 0.87%.
- Chevron's free cash flow yield is 8.06% versus Exxon Mobil's 6.21%.
Earnings intelligence
Over the last four reported quarters, CVX beat EPS estimates each time, while XOM's record is mixed. CVX: 5.28 vs 4.87 consensus (8.42%) on Oct 30, 2026; 6.06 vs 5.55 (9.19%); 1.41 vs 1 (41.00%); 1.52 vs 1.41 (7.80%). XOM: 4.23 vs 4.12 (2.67%); 3.52 vs 3.56 (-1.12%); 1.16 vs 0.984 (17.89%); 1.71 vs 1.7 (0.59%). Revenue surprises were 7.89% for XOM and 9.67% for CVX in the latest quarter. CVX's EPS beat streak is 7 quarters versus 1 for XOM. Stock reactions were small for both after the latest report: XOM -1.98%, CVX -1.59%. Analysts' 30-day EPS revisions are an estimate-based signal: XOM 9.94% is higher than CVX 5.10%, though CVX leads Qanvo's earnings momentum category, driven by surprise size and beat streak. The next report for both is Jan 29, 2027, not confirmed (estimated). No guidance is in the facts. The latest report strengthened CVX's relative case more clearly through the larger beat.
- CVX's latest EPS surprise of 8.42% is above XOM's 2.67%.
- CVX has beaten EPS estimates for 7 straight quarters versus 1 for XOM.
- XOM's 30-day EPS revision of 9.94% is above CVX's 5.10%.
- Both next report on Jan 29, 2027, unconfirmed, 73 days away.
Technicals, relative performance & risk
Price returns favor CVX over 1 month (-3.7% vs -6.2%), 3 months (6.6% vs 3.6%) and 6 months (10.2% vs 4.2%). XOM leads over 1 year (42.1% vs 39.6%), 3 years (60.0% vs 49.7%) and 5 years (160.0% vs 87.3%). With dividends reinvested, 1-year total return is 44.9% for XOM and 45.1% for CVX, so the gap narrows to near parity. Both trade below their 20-day averages (XOM -4.03%, CVX -2.72%) and above their 200-day averages (XOM 6.75%, CVX 10.15%). Versus the 50-day, XOM is -1.44% and CVX 0.16%. RSI is 43.62 for XOM and 47.08 for CVX, both neutral. Relative strength ratings are 87 and 89. XOM sits 11.29% below its 52-week high of 188.50, CVX 8.61% below 236.48. XOM is calmer: 30-day volatility 29.60% vs 26.36% for CVX is actually higher for XOM, yet Qanvo's lower-risk category favors XOM on beta (-0.56 vs -0.51) and short interest. One-year drawdowns are -20.65% and -21.53%. CVX's stronger momentum fits its earnings strength; the fundamentals are less aligned for XOM's weaker short-term trend.
- CVX leads 3-month and 6-month price returns, 6.6% vs 3.6% and 10.2% vs 4.2%.
- XOM leads 5-year price return, 160.0% vs 87.3%.
- CVX is 10.15% above its 200-day average versus 6.75% for XOM.
- XOM's 30-day volatility of 29.60% is higher than CVX's 26.36%.
Analyst & ownership sentiment
Analysts' opinions lean more favorably toward CVX. Its rating score is 2.17 with a consensus label of Buy, against 2.33 (Buy) for XOM, based on 14 and 12 analysts respectively. A separate tally of recommendations shows 34 Buy and 0 Strong Buy for CVX versus 19 Buy and 1 Strong Buy for XOM, but XOM's 31 Holds put its consensus label at Hold. The mean target is 226.80 for CVX (4.94% above the price) and 170.55 for XOM (2.00% above). These are opinions, not forecasts. Estimate revisions over 30 days are 5.10% for CVX and 9.94% for XOM, and neither had upgrades or downgrades in 30 days. Ownership: institutions hold 76.37% of CVX (change over 3 months -1.68%) and 65.87% of XOM (+0.20%). Those holdings come from 13F filings as of 2026-06-30 and lag by weeks. Insiders differ: CVX shows 6 sales and net insider value of -40.3M over 90 days, while XOM shows no insider buys or sells. Short interest is 1.34% of float for CVX and 1.10% for XOM, both low.
- CVX's mean target implies 4.94% upside versus 2.00% for XOM, as analysts' opinions.
- XOM's 30-day EPS estimate revision of 9.94% is above CVX's 5.10%.
- CVX insiders had 6 sales and net value of -40.3M in 90 days, versus none at XOM.
- Short interest is 1.34% of float for CVX and 1.10% for XOM.
Risks & catalysts
Both are integrated oil and gas companies, so earnings depend on commodity cycles. Both show negative expected EPS growth next fiscal year (XOM -9.52%, CVX -10.31%) and 3-year EPS compound declines (-20.35% and -28.69%), and forward figures rest on analysts' estimates. On valuation, forward P/E is 13.33× for XOM and 13.07× for CVX, both above the industry median of 8.51×. XOM's trailing P/E of 17.04× sits above its 5-year median of 14.2, while CVX's 15.68× is close to its median of 15.72. Balance sheet risk is modest for both, but XOM has the stronger resilience score; net debt to EBITDA is 0.27× for XOM versus 0.32× for CVX. CVX's debt to equity is 0.17× against 0.13×. Volatility is higher at XOM (30-day historical volatility 29.60% versus 26.36%). Catalysts: both report next on Jan 29, 2027 (not confirmed). CVX goes ex-dividend on Nov 18, 2026 with a 1.78 payout. XOM's latest ex-date was Nov 16, 2026 at 1.07.
- Expected EPS growth next year is negative for both: XOM -9.52%, CVX -10.31%.
- Forward P/E of 13.33× (XOM) and 13.07× (CVX) is well above the 8.51× industry median.
- XOM's 30-day historical volatility of 29.60% exceeds CVX's 26.36%.
- Next earnings for both are expected Jan 29, 2027, unconfirmed; CVX's ex-dividend date is Nov 18, 2026.
Analysis written November 18, 2026. AI-generated, for information only; not investment advice.